The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(dimethylamino)-1-(1-p-tolyl-3,4-dihydro-1H-pyrido[3,4-b]indol-2(9H)-yl)propan-1-one ID: ALA595512
PubChem CID: 46227702
Max Phase: Preclinical
Molecular Formula: C23H27N3O
Molecular Weight: 361.49
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc(C2c3[nH]c4ccccc4c3CCN2C(=O)CCN(C)C)cc1
Standard InChI: InChI=1S/C23H27N3O/c1-16-8-10-17(11-9-16)23-22-19(18-6-4-5-7-20(18)24-22)12-15-26(23)21(27)13-14-25(2)3/h4-11,23-24H,12-15H2,1-3H3
Standard InChI Key: YAORVKBHKKFOES-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
2.6567 -3.3914 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6555 -4.2187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3704 -4.6316 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3686 -2.9787 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0838 -3.3878 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0841 -4.2187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8746 -4.4753 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.8741 -3.1308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3630 -3.8043 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1859 -3.7182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5265 -2.9598 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.0378 -2.2862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2084 -2.3712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6693 -4.3867 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2715 -5.1068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6983 -5.8118 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5239 -5.7947 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9209 -5.0667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4918 -4.3646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9524 -6.4997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3513 -2.9493 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7729 -3.6585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7547 -2.2297 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.5978 -3.6480 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0193 -4.3570 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.8442 -4.3465 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6160 -5.0767 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11 12 1 0
12 13 1 0
3 6 2 0
10 14 1 0
6 7 1 0
14 15 2 0
7 9 1 0
15 16 1 0
8 5 1 0
16 17 2 0
8 9 2 0
17 18 1 0
1 2 2 0
18 19 2 0
19 14 1 0
5 4 2 0
17 20 1 0
4 1 1 0
11 21 1 0
5 6 1 0
21 22 1 0
21 23 2 0
2 3 1 0
22 24 1 0
8 13 1 0
24 25 1 0
9 10 1 0
25 26 1 0
10 11 1 0
25 27 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 361.49Molecular Weight (Monoisotopic): 361.2154AlogP: 3.90#Rotatable Bonds: 4Polar Surface Area: 39.34Molecular Species: BASEHBA: 2HBD: 1#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 9.15CX LogP: 3.63CX LogD: 1.88Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.77Np Likeness Score: -0.75
References 1. Miller JF, Turner EM, Sherrill RG, Gudmundsson K, Spaltenstein A, Sethna P, Brown KW, Harvey R, Romines KR, Golden P.. (2010) Substituted tetrahydro-beta-carbolines as potential agents for the treatment of human papillomavirus infection., 20 (1): [PMID:19914830 ] [10.1016/j.bmcl.2009.10.123 ]